Public-health information · Research, risks, and help

Signs of Dependence and Withdrawal

A checklist-style guide to signs of dependence, withdrawal symptoms, and when to talk to a clinician.

Updated

6 sources
A calm balance illustration for dependence and withdrawal concerns.
The scale contrasts perceived benefits with concerns about dependence and withdrawal.

Direct answer

Needing a product to avoid feeling unwell is a reason to discuss possible dependence with a clinician. FDA warns about withdrawal, insomnia, and anxiety with concentrated 7-OH; this page is a conversation guide, not a diagnostic test. FDA letter to health care professionals

Tolerance, dependence, and loss of control

Tolerance means a reduced response after repeated exposure. Physical dependence means the body has adapted so that reducing or stopping exposure can produce withdrawal. These are related concepts, but neither should be used alone to label a person's diagnosis.

A mouse study found tolerance and experimental withdrawal after 7-OH exposure. That supports concern, but cannot tell you how quickly dependence will develop in a person or how long their symptoms will last. Matsumoto et al. 2005 tolerance and withdrawal study

Questions to bring to a clinician

  • Has the amount or frequency increased?
  • Do missed or delayed servings bring symptoms?
  • Is use increasingly about avoiding discomfort rather than the original reason for taking it?
  • Have attempts to cut back been difficult to maintain?
  • Is use affecting sleep, finances, work, or relationships?
  • Are alcohol, prescription medicines, other opioids, or sedatives involved?

You do not need to answer yes to every question before asking for help. These prompts are not a validated screening score.

What symptoms should I document?

Record anxiety, sleep disruption, physical symptoms, cravings, and when they occur relative to use. FDA describes opioid-like withdrawal reports, but symptoms alone cannot identify the product, rule out another illness, or establish a diagnosis. FDA 7-OH scientific assessment

There is no single withdrawal calendar offered here. Avoid assuming that an internet timeline will predict your experience.

Preparing for care

Bring the package or a clear photograph. Record the labeled ingredient amounts, servings used, frequency, last use, other substances, and previous attempts to stop. If the amount is unknown, say so rather than estimating it as fact.

Ask the clinician how to assess withdrawal, address the original pain or sleep concern, and arrange follow-up. This guide does not prescribe a taper or recommend replacing 7-OH with another substance.

Emergency or treatment referral?

For suspected overdose, call 911 immediately. If available, give naloxone and stay until emergency help arrives. CDC overdose response guidance

For non-emergency treatment referrals in the United States, call SAMHSA at 1-800-662-4357. SAMHSA National Helpline

For suicidal crisis or emotional distress, call 988 or text 988. This is crisis support, not a substitute for emergency overdose care. 988 Suicide & Crisis Lifeline

See Get Help for the different support pathways.

Sources

  1. FDA 7-OH scientific assessment
  2. Matsumoto et al. 2005 tolerance and withdrawal study
  3. FDA letter to health care professionals
  4. SAMHSA National Helpline
  5. CDC overdose response guidance
  6. 988 Suicide & Crisis Lifeline